Product Information
AMLODIPINE-VALSARTAN 5-160 MG is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2758 per EA under NDC 33342027907. Its NADAC has been published 77 times since Mar 5, 2025.
FDA first approved this application on Oct 11, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 160 mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342027907
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA207292FDA Approved
10/11/2024
TE Code
AB
On Market Since
10/16/2024
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN 5-160 MG has been published 77 times since Mar 5, 2025, and over the history we have for it it has declined 39.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2758 per EA |
|---|---|
| All-time high | $0.4954 (Aug 13, 2025) |
| All-time low | $0.2758 (Aug 19, 2026) |
| 52-week high | $0.4927 |
| 52-week low | $0.2758 |
| Median price | $0.4614 |
| Average price | $0.4475 |
| Largest weekly change | -18.3% (Jul 22, 2026) |
| Weeks tracked | 77 |
| Tracking since | Mar 5, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN 5-160 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-160 MG, manufactured by Macleods Pharmaceuticals Limited, is $0.2758 per EA (NDC 33342027907), effective Aug 19, 2026.
How has the price of AMLODIPINE-VALSARTAN 5-160 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has declined 39.2%. It has been tracked across 77 weekly CMS publications since Mar 5, 2025.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-160 MG?
Since Mar 5, 2025, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has ranged from a low of $0.2758 (Aug 19, 2026) to a high of $0.4954 (Aug 13, 2025), with a median of $0.4614 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-160 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-VALSARTAN 5-160 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-VALSARTAN 5-160 MG?
AMLODIPINE-VALSARTAN 5-160 MG (NDC 33342027907) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.